Chiropractors in Burwell, NE Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Roberts Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 177 S 8th Ave, Burwell, NE 68823 Phone: 308-346-5191 |
 Marie Ernesti, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 177 S 8th Ave, Burwell, NE 68823 Phone: 308-346-5191 |
Sandhills Chiropractic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 147 S 8th Ave, Burwell, NE 68823 Phone: 308-214-1525 |
Dr. Jamie Christina Chaffin, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 147 S 8th St, Burwell, NE 68823 Phone: 308-346-5191 Fax: 308-346-5191 |
Chaffin Chiropractic Clinic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 147 S 8th St, Burwell, NE 68823 Phone: 308-346-5191 Fax: 308-346-5191 |
Lilly A. Walford, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 147 S 8th Ave, Burwell, NE 68823 Phone: 308-214-1525 |
News Archive
Strain of the bacteria Streptococcus pneumoniae that causes ear infections emerges; resistant to antibiotics, pneumococcal vaccine
A strain of the bacteria Streptococcus pneumoniae, which can cause ear infections in children, has been detected that is resistant to all FDA-approved antibiotics for treatment of ear infections and is not covered by the pneumococcal 7-valent conjugate vaccine, according to a study in the October 17 issue of JAMA.
LSD for alcohol addiction: Study
Hallucinogenic drug LSD (lysergic acid diethylamide) could help alcoholics give up drinking, according to an analysis of studies performed in the 1960s. A study, presented in the Journal of Psychopharmacology, looked at data from six trials and more than 500 patients. It said there was a "significant beneficial effect" on alcohol abuse, which lasted several months after the drug was taken.
New diagnostic test detects and identifies SARS-CoV-2 virus in less than five minutes
Scientists from Oxford University's Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.
Positive results from Protalix BioTherapeutics Phase III UPLYSO clinical trial
Protalix BioTherapeutics, Inc., announced today positive top-line results from the Company's pivotal Phase III clinical trial of UPLYSO (taliglucerase alfa, previously referred to as prGCD) in treatment naive patients diagnosed with Gaucher disease.
› Verified 8 days ago